- Zacks•2 days ago
AstraZeneca (AZN) reported second-quarter 2016 core earnings of 83 cents per American Depositary Share, beating the Zacks Consensus Estimate of 42 cents.
- TheStreet.com•3 days ago
AstraZeneca (AZN) stock is increasing this afternoon after the company reported better-than-expected results before today's market open.
|Bid||4,850.00 x 6100|
|Ask||5,149.00 x 13000|
|52wk Range||3,680.00 - 5,114.00|
|Day's Range||4,918.00 - 5,114.00|
|Avg Vol (3m)||2,697,842|
As of 12:09 PM EDT. Market closed.